Skip to main navigation Skip to search Skip to main content

Treating mammalian bite wounds

  • GlaxoSmithKline
  • University of North Carolina at Chapel Hill
  • Duke University
  • Campbell University

Research output: Contribution to journalReview articlepeer-review

108 Scopus citations

Abstract

The incidence of dog, cat and human bites has been increasing steadily and represents an important cause of morbidity and mortality in the United States. Approximately half of all Americans will suffer a bite wound during their lifetime, and the annual medical costs of managing these injuries has been estimated to be over $100 million. Possible complications may include disfigurement, dismemberment and infection. Effective management requires rapid medical evaluation and may necessitate surgical intervention and prophylactic antibiotic therapy. As bite wounds are microbiologically diverse and most often polymicrobial in nature, selection of an appropriate antibiotic regimen requires knowledge of common pathogens. Close clinical follow-up is recommended to minimize the risk of late complications.

Original languageEnglish
Pages (from-to)85-99
Number of pages15
JournalJournal of Clinical Pharmacy and Therapeutics
Volume25
Issue number2
DOIs
StatePublished - 2000

Fingerprint

Dive into the research topics of 'Treating mammalian bite wounds'. Together they form a unique fingerprint.

Cite this